Market analyst Ashwani Gujral has suggested five BUY calls and no SELL call for today’s session, suggesting a bullish outlook for markets.

Market expert Sanjiv Bhasin has suggested five stocks for investors and medium-term outlook traders for August in the pharmaceutical segment.

Gilead Sciences signed a contract with four Indian pharmaceutical companies to produce its medication ‘Remdesivir’ which has been found effective in treatment of some COVID-19 patients.

Market analyst Ashwani Gujral suggested five BUY Calls and no SELL call for today’s session and TopNews has reviewed the trading call performance for today’s session Indian markets firmed up on Fri

Market analyst Ashwani Gujral has suggested five BUY Calls and no SELL call for today’s session, suggesting a bullish outlook.

Markets analyst Mitesh Thakkar has suggested two SELL calls and two BUY calls for today’s trading session.